{
    "clinical_study": {
        "@rank": "89061", 
        "acronym": "MeDyA", 
        "arm_group": [
            {
                "arm_group_label": "Fibromuscular dysplasia", 
                "arm_group_type": "Other", 
                "description": "Fibromuscular dysplasia:blood samples & vascular echotracking"
            }, 
            {
                "arm_group_label": "healthy volunteer", 
                "arm_group_type": "Other", 
                "description": "healthy volunteer:blood samples & vascular echotracking"
            }, 
            {
                "arm_group_label": "hypertensive patients", 
                "arm_group_type": "Other", 
                "description": "hypertensive patients:blood samples & vascular echotracking"
            }
        ], 
        "brief_summary": {
            "textblock": "Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial\n      disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown\n      origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of\n      narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery,\n      arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several\n      factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order\n      to progress into identifying possible causative mechanisms of the disease, we design a\n      pathophysiology study destined to assess endothelial function in patients with fibromuscular\n      dysplasia and to identify possible plasmatic biomarkers of the disease."
        }, 
        "brief_title": "Pathophysiological Mechanisms of Fibromuscular Dysplasia", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Fibromuscular Dysplasia", 
        "condition_browse": {
            "mesh_term": "Fibromuscular Dysplasia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for patients with multifocal fibromuscular dysplasia:\n\n          -  confirmed multifocal fibromuscular dysplasia\n\n          -  diagnosed for less than 10 years\n\n          -  without significant atherosclerotic disease or recent cardiovascular event\n\n          -  Statins and antiplatelet drugs are forbidden\n\n          -  hypertensive patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01935752", 
            "org_study_id": "P110301"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Fibromuscular dysplasia", 
                    "healthy volunteer", 
                    "hypertensive patients"
                ], 
                "description": "blood samples", 
                "intervention_name": "blood samples", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Fibromuscular dysplasia", 
                    "healthy volunteer", 
                    "hypertensive patients"
                ], 
                "description": "endothelial function study and virtual histology study", 
                "intervention_name": "vascular echotracking", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "fibromuscular", 
            "dysplasia", 
            "endothelium", 
            "microparticles", 
            "microRNA"
        ], 
        "lastchanged_date": "September 2, 2013", 
        "location": {
            "contact": {
                "email": "michael.frank@egp.aphp.fr", 
                "last_name": "Michael Frank, MD, Msc", 
                "phone": "0156093066", 
                "phone_ext": "01133"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "Cic9201, Hegp, Aphp,"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Pathophysiological Mechanisms of Fibromuscular Dysplasia", 
        "overall_contact": {
            "email": "michael.frank@egp.aphp.fr", 
            "last_name": "Michael Frank, MD, Msc.", 
            "phone": "0156093066", 
            "phone_ext": "01133"
        }, 
        "overall_contact_backup": {
            "email": "michel.azizi@egp.aphp.fr", 
            "last_name": "Michel Azizi, MD, PhD.", 
            "phone": "0156092945", 
            "phone_ext": "01133"
        }, 
        "overall_official": {
            "affiliation": "HEGP, APHP, Paris, France", 
            "last_name": "Michel Azizi, MD, PhD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients", 
            "safety_issue": "No", 
            "time_frame": "Once within 15 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01935752"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Comparison of circulating micro RNAs (miR-143 ; miR-145) between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }, 
            {
                "measure": "Comparison of matrixmetalloproteases between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }, 
            {
                "measure": "Comparison of c-reactive protein between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }, 
            {
                "measure": "Comparison of PLA2 between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }, 
            {
                "measure": "Comparison of endothelium dependant vasodilation between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }, 
            {
                "measure": "Comparison of endothelium independent vasodilation between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }, 
            {
                "measure": "Comparison of pulse wave velocity between the 3 arms", 
                "safety_issue": "No", 
                "time_frame": "Once within 15 days"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "collaborator": {
                "agency": "Fondation pour la Recherche M\u00e9dicale", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}